Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Farrokh Dehdashti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6019-3997; OpenAlex author ID A5003894390; NIH RePORTER profile ID 1955384. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
2
Labs led
1
Collaborators
8
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper, 1 grant · 2025: none · 2026: 1 grant

Papers 2

  1. Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acsptsci.3c00303↗
  2. CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acsnano.0c08185↗

Trials 1

  1. PET Imaging of PARP Activity in Cancer Principal investigator NCT02469129↗

Grants 2

  1. PET Imaging CD163+ Tumor Associated Macrophages in Head and Neck Cancer R01CA316361↗
  2. Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy R01CA235672↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongjian Liu · 2 shared papers, 2 shared grants, 2021–2026 · strength 2.00
  2. Kian‐Huat Lim · 2 shared papers, 1 shared grant, 2021–2024 · strength 1.00
  3. Sidharth V. Puram · 1 shared grant, 2026 · strength 1.00
  4. Xiaohui Zhang · 2 shared papers, 2021–2024 · strength 0.28
  5. Liang‐I Kang · 1 shared paper, 2024 · strength 0.17
  6. Vikas Somani · 1 shared paper, 2024 · strength 0.17
  7. David G DeNardo · 1 shared paper, 2024 · strength 0.17
  8. Patrick M. Grierson · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.